ALS disease mechanism in adults
Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that primarily affects motor neurons—the nerve cells responsible for controlling voluntary muscle movements. In adults, the mechanism of ALS involves a complex interplay of genetic, molecular, and environmental factors that lead to neuron degeneration and muscle wasting.
The core pathology of ALS centers around the deterioration of upper motor neurons in the brain and lower motor neurons in the spinal cord. This degeneration results in the loss of neural signals necessary for muscle contraction, ultimately causing muscle weakness, atrophy, and paralysis. While the exact cause of ALS remains unknown in many cases, a significant proportion is linked to genetic mutations, with the most common being mutations in the SOD1 gene. These genetic alterations can lead to abnormal protein accumulation, oxidative stress, and mitochondrial dysfunction, which are critical in neuron death.
One prominent mechanism involved in ALS is protein misfolding and aggregation. Faulty proteins, such as TDP-43 and SOD1, tend to misfold and form insoluble inclusions within neurons. These aggregates disrupt cellular functions, impair proteostasis, and trigger inflammatory responses, contributing to neuronal death. Additionally, impaired autophagy—a process responsible for clearing damaged cellular components—further exacerbates protein accumulation and neuronal stress.
Oxidative stress plays a vital role in the disease’s progression. Damaged mitochondria produce excessive reactive oxygen species (ROS), which damage cellular DNA, proteins, and lipids. This oxidative damage accelerates neuronal degeneration and impairs the cells’ ability to recover. Moreover, excitotoxicity, caused by excessive glutamate release, results in calcium overload within neurons, leading to cellular injury and apoptosis.
Neuroinflammation is another critical aspect of ALS pathology. Microglia and astrocytes, the brain‘s support cells, become activated in response to neuronal damage. While initially protective, chronic activation leads to the release of inflammatory cytokines and neurotoxic substances, which further damage motor neurons. This creates a vicious cycle where neuronal death incites inflammation, which in turn accelerates neurodegeneration.
The disease also involves disruptions in RNA metabolism and cellular transport mechanisms. Abnormalities in the transport of organelles and proteins within neurons impair cellular health and contribute to the vulnerability of motor neurons to degeneration. These combined molecular disturbances result in a progressive loss of motor function.
In summary, adult-onset ALS is driven by a multifaceted network of pathogenic mechanisms, including protein misfolding, oxidative stress, excitotoxicity, neuroinflammation, and disrupted cellular transport. Understanding these processes is crucial for developing targeted therapies aimed at slowing or halting disease progression.